Previous Close | 43.60 |
Open | 43.01 |
Bid | 41.63 x 100 |
Ask | 42.24 x 100 |
Day's Range | 42.00 - 43.10 |
52 Week Range | 19.14 - 48.85 |
Volume | |
Avg. Volume | 616,180 |
Market Cap | 1.771B |
Beta (5Y Monthly) | 1.74 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Launches high-value product in Germany & Switzerland with capability to pay veterinarians directlySEATTLE, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leading global provider of medical insurance for cats and dogs, announced today the official launch of its high-quality Trupanion product in Germany and Switzerland. The launch follows the Company’s expansion to Continental Europe in 2022 with the acquisition of two rapidly growing pet insurance companies with strong exp
Trupanion shares insights into corporate governance, commitment to sustainability, and more in their latest Corporate Social Responsibility ReportSEATTLE, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs in North America, announced today that they have published their fourth corporate social responsibility report. The report is now available on Trupanion’s Investor Relations website here. About Trupanion Trupanion is a
Boehringer Ingelheim, Mars Science & Diagnostics and leading pet, public health and animal health authorities to join Advisory Board Collaboration to address emerging pet and public health threats to protect pets and peopleEarly detection potential has global pet and public health benefits SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs in North America, in partnership with the Centers for Disease Control and